Neoadjuvant Chemoradiotherapy versus Chemotherapy for Gastroesophageal Junction Adenocarcinoma; Which Is the Optimal Treatment Option?

Neoadjuvant Chemoradiotherapy versus Chemotherapy for Gastroesophageal Junction Adenocarcinoma; Which Is the Optimal Treatment Option?

<i>Background</i>: Locally advanced gastroesophageal junction adenocarcinoma (GEJ) is treated with either perioperative chemotherapy (CT) or preoperative radiochemotherapy (RCT) followed by surgery. The aim of this study was to compare pathologic response and long-term outcomes in juncti...

Full description

Bibliographic Details
Main Authors: Eric Zandirad, Hugo Teixeira Farinha, Beatriz Barberá-Carbonell, Sandrine Geinoz, Nicolas Demartines, Markus Schäfer, Styliani Mantziari
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Cancers
Subjects:
neoadjuvant chemoradiotherapy
neoadjuvant chemotherapy
gastroesophageal junction adenocarcinoma
gastroesophageal junction
neoadjuvant treatment
overall survival
Online Access:https://www.mdpi.com/2072-6694/14/23/5856

Internet

https://www.mdpi.com/2072-6694/14/23/5856

Similar Items